VACCINEX, INC. ANNOUNCES $60 MILLION AGREEMENT TO FINANCE A PHASE 2B CLINICAL TRIAL OF PEPINEMAB TO TREAT ALZHEIMER’S DISEASE

Reuters · 2d ago

Please log in to view news